Food Companies Expect More Consumers to Worry About Toxins

The article below follows reporting in The Wall Street Journal (mid-March 2026). Elijah W Group does not own this journalism; we set it out in full for clients who track consumer-facing risk, chemicals policy, litigation, and food-sector strategy. The WSJ’s exact wording, additional context, and updates are available to subscribers at the link below.

Food, beverage, and restaurant companies are preparing for a sustained rise in consumer concern about trace contaminants—not only calories and sugar, but chemicals linked to packaging, processing, water, and the wider supply chain. What was once treated as a niche “clean living” conversation is, in the Journal’s account, increasingly treated as a mainstream driver of brand choice, reformulation, and capital-markets risk.

Policy attention and the MAHA moment

The Journal ties heightened attention in part to the Make America Healthy Again (MAHA) agenda and the profile of U.S. Health and Human Services Secretary Robert F. Kennedy Jr., arguing that debate over chemical safety has spread beyond traditional environmental circles. The reporting places food dyes, pesticide residues, and related issues alongside longer-running worries about industrial contaminants—widening the set of substances and practices that draw political and media scrutiny.

What surveys cited in the story suggest

According to survey research cited in the Journal—including work by Pew Research Center—a large majority of U.S. adults express concern about harmful chemical exposure from food, drinking water, packaging, and related sources. The piece also notes that roughly five in six respondents want government and companies to do more to ensure chemical safety and transparency, underscoring the gap between public expectation and how quickly supply chains can adapt.

What companies are telling investors

The Wall Street Journal highlights risk disclosures by major operators that treat “toxin” anxiety as a material business issue. Among the examples in the reporting are The Cheesecake Factory, Mondelez International (maker of brands such as Oreo), Texas Roadhouse, and Hershey. In filings and investor communications, such companies flag the possibility that demand could shift toward products perceived as free of certain chemicals, alongside knock-on effects on sourcing, reformulation cost, shelf life, and margins.

The article also emphasises secondary channels of risk: supply-chain disruption if inputs or packaging must be replaced; litigation and reputational damage when contaminants become headline news; and a patchwork of new regulatory obligations as states and the federal government respond at different speeds.

Specific themes that show up across those disclosures, in the Journal’s summary, include so-called forever chemicals (PFAS), microplastics, and heavy metals—each with different pathways into food (packaging, equipment, agricultural inputs, and the environment) and different scientific and legal contours.

States, Congress, and the compliance map

The reporting describes a busy legislative layer beneath federal rulemaking: several states have adopted or proposed measures touching PFAS, microplastics, or related substances in food contact materials or packaging. At the federal level, the Journal notes bipartisan interest in requiring a government report on health harms associated with such exposures—an example of how disclosure and evidence-gathering can precede harder national standards.

For global food businesses, that pattern—state laboratories of regulation, investor pressure, and uneven international rules—can complicate product design and marketing claims. A formulation that satisfies one jurisdiction may still attract questions in another, or from plaintiffs’ counsel citing consumer-protection theories.

Implications for brands and advisors

The through-line for operators is strategic rather than purely technical: map realistic exposure paths across ingredients, water, equipment, and packaging; align R&D and procurement with emerging constraints before crises force reactive recalls or reformulations; and build communications that can withstand scientific uncertainty—neither over-claiming “free from” language nor dismissing legitimate questions from customers, regulators, or courts.

For investors and boards, the Journal’s framing suggests ESG and litigation dashboards should treat chemical risk as connected to brand equity and insurance costs, not only to environmental compliance in the narrow sense. First movers on transparent testing and supplier standards may pay upfront—but may also reduce tail risk if the next news cycle targets their category.

Source

Read the original Wall Street Journal article for complete quotations, data, and any subsequent corrections or updates (subscription may apply).

Open the WSJ article →